zika virus purified inactivated vaccine
Vaccineexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2016 (NCT02937233)
Timeline
2010s
- Jan 1, 2016
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Zika virusImmunity, active
immunity, active - Zika virus
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- zika virus purified inactivated vaccine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03008122 | Phase 1 | Feb 24, 2017 | National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT02963909 | Phase 1 | Nov 1, 2016 | National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT02937233 | Phase 1 | Oct 1, 2016 | Harvard University, National Institute of Allergy and Infectious Diseases (NIAID), United States Army |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 3 | 2 | 1 | 2016 |
| Harvard University | Academic/Hospital | 1 | 1 | 1 | 2016 |
| United States Army | Government | 1 | 0 | 1 | 2016 |
3 organizations
Page 1 / 1